LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 127

Search options

  1. Article: Decreased Need for Correction Boluses with Universal Utilisation of Dual-Wave Boluses in Children with Type 1 Diabetes.

    Lukka, Mari / Tillmann, Vallo / Peet, Aleksandr

    Journal of clinical medicine

    2022  Volume 11, Issue 6

    Abstract: ... with the second part extended over 2 h. After two weeks patients switched into the alternative treatment arm. TIR ...

    Abstract Insulin pumps offer standard (SB), square and dual-wave boluses (DWB). Few recommendations exist on how to use these dosing options. Several studies suggest that the DWB is more effective for high-fat or high-carbohydrate meals. Our objective was to test whether time in range (TIR) improves in children with type 1 diabetes (T1D) using the universal utilization of the dual-wave boluses for all evening meals regardless of the composition of the meal. This was a 28-day long prospective randomized open-label single-center crossover study. Twenty-eight children with T1DM using a Medtronic 640G pump and continuous glucose monitoring system were randomly assigned to receive either DWB or SB for all meals starting from 6:00 p.m. based solely on the food carbohydrate count. DWB was set for 50/50% with the second part extended over 2 h. After two weeks patients switched into the alternative treatment arm. TIR (3.9−10 mmol/L), time below range (TBR) (<3.9 mmol/L) and time above range (TAR) (>10 mmol/L) and sensor glucose values were measured and compared between the groups. Twenty-four children aged 7−14 years completed the study according to the study protocol. There were no statistically significant differences in mean TIR (60.9% vs. 58.8%; p = 0.3), TBR (1.6% vs. 1.7%; p = 0.7) or TAR (37.5 vs. 39%; p = 0.5) between DWB and SB groups, respectively. Subjects in the DWB treatment arm administered significantly less correction boluses between 6 p.m. and 6 a.m. compared to those in the SB group (1.2 ± 0.8 vs. 1.7 ± 0.8, respectively; p < 0.01). DWB for evening meals in which insulin is calculated solely on the food carbohydrate content did not improve TIR compared to standard bolus in children with T1D. However, DWB enabled to use significantly less correction boluses to achieve euglycemia by the morning compared to the SB.
    Language English
    Publishing date 2022-03-18
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm11061689
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Why do adults seek treatment for gaming (disorder)? A qualitative study

    Veli-Matti Karhulahti / Sanni Behm / Lauri Lukka

    Humanities & Social Sciences Communications, Vol 10, Iss 1, Pp 1-

    2023  Volume 8

    Abstract: Abstract Despite gaming disorder now being diagnosable by the International Classification of Diseases (ICD-11) as a new mental disorder due to addictive behaviors, little is known about the concrete reasons for which people seek treatment for their ... ...

    Abstract Abstract Despite gaming disorder now being diagnosable by the International Classification of Diseases (ICD-11) as a new mental disorder due to addictive behaviors, little is known about the concrete reasons for which people seek treatment for their videogame play. As the current literature is mainly based on children and adolescents, there is a strong need for better understanding adult treatment-seekers in particular. This preregistered study responds to the gap in research by qualitatively investigating the reasons for treatment-seeking with 110 participants who had sought help for their videogame play from a Finnish treatment program. We applied template analysis to the open-ended data, which consist of the participants’ personal accounts regarding their problems. Additionally, we report the game titles that the participants had problems with, as well as Internet Gaming Disorder Test (IGDT-10) scores, which were measured from 89 participants. The template analysis suggested five themes, which cover the main reasons for treatment-seeking: social reasons, existential reasons, practical reasons, self-perceived addiction, and wish for support. Many of these themes overlap with the ICD-11 description of gaming disorder, but several issues, such as loss of meaning and financial harms, are not part of the current diagnosis. The average IGDT-10 score among participants was 3.86 (SD = 2.55) and 37 (42%) individuals met the disorder cutoff (5.00). Numerous videogames with different designs were mentioned as sources of problems, of which 26 were mentioned more than once. The study indicates that adults seek treatment for many kinds of games and gaming-related problems, including but not limited to those, which are described part of the ICD-11 gaming disorder diagnoses. We recommend both researchers and practitioners to implement an expanded perspective on gaming behaviors, acknowledging that adults may seek treatment for diverse gaming-related problems, some of which not necessarily relevant to gaming disorder or ...
    Keywords History of scholarship and learning. The humanities ; AZ20-999 ; Social Sciences ; H
    Subject code 150
    Language English
    Publishing date 2023-06-01T00:00:00Z
    Publisher Springer Nature
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: The evolution of fractionated prostate cancer radiotherapy.

    Catton, Charles / Lukka, Himu

    Lancet (London, England)

    2019  Volume 394, Issue 10196, Page(s) 361–362

    MeSH term(s) Dose Fractionation, Radiation ; Humans ; Male ; Prostatic Neoplasms
    Language English
    Publishing date 2019-06-18
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 3306-6
    ISSN 1474-547X ; 0023-7507 ; 0140-6736
    ISSN (online) 1474-547X
    ISSN 0023-7507 ; 0140-6736
    DOI 10.1016/S0140-6736(19)31338-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Adherence to oral hormonal therapy in advanced prostate cancer: a scoping review.

    Fleshner, Neil E / Alibhai, Shabbir M H / Connelly, Kim A / Martins, Ilidio / Eigl, Bernhard J / Lukka, Himu / Aprikian, Armen

    Therapeutic advances in medical oncology

    2023  Volume 15, Page(s) 17588359231152845

    Abstract: Background: Orally administrated agents play a key role in the management of prostate cancer, providing a convenient and cost-effective treatment option for patients. However, they are also associated with adherence issues which can compromise ... ...

    Abstract Background: Orally administrated agents play a key role in the management of prostate cancer, providing a convenient and cost-effective treatment option for patients. However, they are also associated with adherence issues which can compromise therapeutic outcomes. This scoping review identifies and summarizes data on adherence to oral hormonal therapy in advanced prostate cancer and discusses associated factors and strategies for improving adherence.
    Methods: PubMed (inception to 27 January 2022) and conference databases (2020-2021) were searched to identify English language reports of real-world and clinical trial data on adherence to oral hormonal therapy in prostate cancer using the key search terms 'prostate cancer' AND 'adherence' AND 'oral therapy' OR respective aliases.
    Results: Most adherence outcome data were based on the use of androgen receptor pathway inhibitors in metastatic castration-resistant prostate cancer (mCRPC). Self-reported and observer-reported adherence data were used. The most common observer-reported measure, medication possession ratio, showed that the vast majority of patients were in possession of their medication, although proportion of days covered and persistence rates were considerably lower, raising the question whether patients were consistently receiving their treatment. Study follow-up for adherence was generally around 6 months up to 1 year. Studies also indicate that persistence may drop further with longer follow-up, especially in the non-mCRPC setting, which may be a concern when years of therapy are required.
    Conclusions: Oral hormonal therapy plays an important role in the treatment of advanced prostate cancer. Data on adherence to oral hormonal therapies in prostate cancer were generally of low quality, with high heterogeneity and inconsistent reporting across studies. Short study follow-up for adherence and focus on medication possession rates may further limit relevance of available data, especially in settings that require long-term treatment. Additional research is required to comprehensively assess adherence.
    Language English
    Publishing date 2023-03-29
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2503443-1
    ISSN 1758-8359 ; 1758-8340
    ISSN (online) 1758-8359
    ISSN 1758-8340
    DOI 10.1177/17588359231152845
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The Journey of Radiotherapy Dose Escalation in High Risk Prostate Cancer; Conventional Dose Escalation to Stereotactic Body Radiotherapy (SBRT) Boost Treatments.

    Mesci, Aruz / Isfahanian, Naghmeh / Dayes, Ian / Lukka, Himu / Tsakiridis, Theodoros

    Clinical genitourinary cancer

    2021  Volume 20, Issue 1, Page(s) e25–e38

    Abstract: High risk prostate cancer (HR-PrCa) is a subset of localized PrCa with significant potential for morbidity and mortality associated with disease recurrence and metastasis. Radiotherapy combined with Androgen Deprivation Therapy has been the standard of ... ...

    Abstract High risk prostate cancer (HR-PrCa) is a subset of localized PrCa with significant potential for morbidity and mortality associated with disease recurrence and metastasis. Radiotherapy combined with Androgen Deprivation Therapy has been the standard of care for many years in HR-PrCa. In recent years, dose escalation, hypo-fractionation and high precision delivery with immobilization and image-guidance have substantially changed the face of modern PrCa radiotherapy, improving treatment convenience and outcomes. Ultra-hypo-fractionated radiotherapy delivered with high precision in the form of stereotactic body radiation therapy (SBRT) combines delivery of high biologically equivalent dose radiotherapy with the convenience of a shorter treatment schedule, as well as the promise of similar efficacy and reduced toxicity compared to conventional radiotherapy. However, rigorous investigation of SBRT in HR-PrCa remains limited. Here, we review the changes in HR-PrCa radiotherapy through dose escalation, hypo- and ultra-hypo-fractionated radiotherapy boost treatments, and the radiobiological basis of these treatments. We focus on completed and on-going trials in this disease utilizing SBRT as a sole radiation modality or as boost therapy following pelvic radiation.
    MeSH term(s) Androgen Antagonists/therapeutic use ; Dose Fractionation, Radiation ; Humans ; Male ; Neoplasm Recurrence, Local ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/surgery ; Radiosurgery/adverse effects ; Radiosurgery/methods
    Chemical Substances Androgen Antagonists
    Language English
    Publishing date 2021-10-08
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2225121-2
    ISSN 1938-0682 ; 1558-7673
    ISSN (online) 1938-0682
    ISSN 1558-7673
    DOI 10.1016/j.clgc.2021.09.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Decreased Need for Correction Boluses with Universal Utilisation of Dual-Wave Boluses in Children with Type 1 Diabetes

    Mari Lukka / Vallo Tillmann / Aleksandr Peet

    Journal of Clinical Medicine, Vol 11, Iss 1689, p

    2022  Volume 1689

    Abstract: ... with the second part extended over 2 h. After two weeks patients switched into the alternative treatment arm. TIR ...

    Abstract Insulin pumps offer standard (SB), square and dual-wave boluses (DWB). Few recommendations exist on how to use these dosing options. Several studies suggest that the DWB is more effective for high-fat or high-carbohydrate meals. Our objective was to test whether time in range (TIR) improves in children with type 1 diabetes (T1D) using the universal utilization of the dual-wave boluses for all evening meals regardless of the composition of the meal. This was a 28-day long prospective randomized open-label single-center crossover study. Twenty-eight children with T1DM using a Medtronic 640G pump and continuous glucose monitoring system were randomly assigned to receive either DWB or SB for all meals starting from 6:00 p.m. based solely on the food carbohydrate count. DWB was set for 50/50% with the second part extended over 2 h. After two weeks patients switched into the alternative treatment arm. TIR (3.9–10 mmol/L), time below range (TBR) (<3.9 mmol/L) and time above range (TAR) (>10 mmol/L) and sensor glucose values were measured and compared between the groups. Twenty-four children aged 7–14 years completed the study according to the study protocol. There were no statistically significant differences in mean TIR (60.9% vs. 58.8%; p = 0.3), TBR (1.6% vs. 1.7%; p = 0.7) or TAR (37.5 vs. 39%; p = 0.5) between DWB and SB groups, respectively. Subjects in the SB treatment arm administered significantly less correction boluses between 6 p.m. and 6 a.m. compared to those in the DWB group (1.2 ± 0.8 vs. 1.7 ± 0.8, respectively; p < 0.01). DWB for evening meals in which insulin is calculated solely on the food carbohydrate content did not improve TIR compared to standard bolus in children with T1D. However, DWB enabled to use significantly less correction boluses to achieve euglycemia by the morning compared to the SB.
    Keywords type 1 diabetes ; insulin pump therapy ; CGM ; meal bolus ; dual wave bolus ; standard bolus ; Medicine ; R
    Language English
    Publishing date 2022-03-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study).

    Wedner, H James / Fujisawa, Takao / Guilbert, Theresa W / Ikeda, Masanori / Mehta, Vinay / Tam, Jonathan S / Lukka, Pradeep B / Asimus, Sara / Durżyński, Tomasz / Johnston, James / White, Wendy I / Shah, Mihir / Werkström, Viktoria / Jison, Maria L

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

    2024  Volume 35, Issue 3, Page(s) e14092

    Abstract: Background: Benralizumab is an anti-interleukin-5 receptor α monoclonal antibody approved as an add-on maintenance treatment for patients with uncontrolled severe asthma. Prior Phase 3 studies have evaluated benralizumab in patients aged ≥12 years with ... ...

    Abstract Background: Benralizumab is an anti-interleukin-5 receptor α monoclonal antibody approved as an add-on maintenance treatment for patients with uncontrolled severe asthma. Prior Phase 3 studies have evaluated benralizumab in patients aged ≥12 years with severe uncontrolled asthma. The TATE study evaluated the pharmacokinetics (PK), pharmacodynamics (PD), and safety of benralizumab treatment in children.
    Methods: TATE was an open-label, Phase 3 study of benralizumab in children aged 6-11 years from the United States and Japan (plus participants aged 12-14 years from Japan) with severe eosinophilic asthma. Participants received benralizumab 10/30 mg according to weight (<35/≥35 kg). Primary endpoints included maximum serum concentration (C
    Results: Twenty-eight children aged 6-11 years were included, with an additional two participants from Japan aged 12-14 years also included in the popPK analysis. Mean C
    Conclusion: PK, PD, and safety data support long-term benralizumab in children with severe eosinophilic asthma, and were similar to findings in adolescents and adults.
    Trial registration: ClinicalTrials.gov-ID: NCT04305405.
    MeSH term(s) Adult ; Child ; Adolescent ; Humans ; Anti-Asthmatic Agents/adverse effects ; Disease Progression ; Double-Blind Method ; Asthma/drug therapy ; Asthma/chemically induced ; Eosinophils ; Antibodies, Monoclonal, Humanized
    Chemical Substances Anti-Asthmatic Agents ; benralizumab (71492GE1FX) ; Antibodies, Monoclonal, Humanized
    Language English
    Publishing date 2024-03-16
    Publishing country England
    Document type Journal Article
    ZDB-ID 1057059-7
    ISSN 1399-3038 ; 0905-6157 ; 0906-5784
    ISSN (online) 1399-3038
    ISSN 0905-6157 ; 0906-5784
    DOI 10.1111/pai.14092
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Evaluation of Volumetric Response Assessment From SABR for Renal Cell Carcinoma (RCC).

    Schep, Daniel G / Vansantvoort, Jasmin / Dayes, Ian / Lukka, Himanshu / Quan, Kimmen / Kapoor, Anil / Chow, Tom / Chu, William / Swaminath, Anand

    International journal of radiation oncology, biology, physics

    2023  

    Abstract: Purpose: SABR is increasingly used to treat renal cell carcinoma (RCC). However, the optimal method to assess treatment response is unclear. We aimed to quantify changes in both volume and maximum linear size of tumors after SABR and evaluate the ... ...

    Abstract Purpose: SABR is increasingly used to treat renal cell carcinoma (RCC). However, the optimal method to assess treatment response is unclear. We aimed to quantify changes in both volume and maximum linear size of tumors after SABR and evaluate the utility of the 2 approaches in treatment response assessment.
    Methods and materials: We retrospectively studied patients with RCC treated with SABR at our institution between 2013 and 2020. All available follow-up computed tomography scans were aligned, and tumors were contoured on all scans. Volume and maximum linear size were measured at each follow-up, relative to these measurements at the time of computed tomography simulation.
    Results: Twenty-four patients with 25 tumors were included. Median follow-up was 32 months (range, 16-67). Nineteen tumors (76%) had 30% volumetric response at a median time of 7 months after SABR, and 12 tumors (48%) had 30% decrease in maximum linear size at a median time of 16 months. Eighteen tumors (72%) decreased in volume on first follow-up scan and continued to shrink, and 5 tumors (20%) displayed transient growth after SABR (average 24% increase in volume). Compared with T1a tumors, T1b or larger tumors were more likely to have transient growth (8% vs 33%; P = .16) and had higher average relative volume 24 months after SABR (0.47 vs 0.8; P = .022).
    Conclusions: Volume measurement results in more pronounced and earlier change compared with linear size measurement when assessing response to SABR. These findings may provide guidance when assessing treatment response for patients with RCC treated with SABR.
    Language English
    Publishing date 2023-12-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 197614-x
    ISSN 1879-355X ; 0360-3016
    ISSN (online) 1879-355X
    ISSN 0360-3016
    DOI 10.1016/j.ijrobp.2023.12.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: In favour of bladder preservation using combined modality treatment.

    Lukka, Himu

    Canadian Urological Association journal = Journal de l'Association des urologues du Canada

    2009  Volume 3, Issue 5, Page(s) 412–415

    Language English
    Publishing date 2009-10-12
    Publishing country Canada
    Document type Journal Article
    ZDB-ID 2431403-1
    ISSN 1911-6470
    ISSN 1911-6470
    DOI 10.5489/cuaj.1157
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Insight into soft chemometric computational learning for modelling oily-wastewater separation efficiency and permeate flux of polypyrrole-decorated ceramic-polymeric membranes.

    Baig, Umair / Usman, Jamil / Abba, Sani I / Yogarathinam, Lukka Thuyavan / Waheed, Abdul / Bafaqeer, Abdullah / Aljundi, Isam H

    Journal of chromatography. A

    2024  Volume 1725, Page(s) 464897

    Abstract: Reliable modeling of oily wastewater emphasizes the paramount importance of sustainable and health-conscious wastewater management practices, which directly aligns with the Sustainable Development Goals (SDG) while also meeting the guidelines of the ... ...

    Abstract Reliable modeling of oily wastewater emphasizes the paramount importance of sustainable and health-conscious wastewater management practices, which directly aligns with the Sustainable Development Goals (SDG) while also meeting the guidelines of the World Health Organization (WHO). This research explores the efficiency of utilizing polypyrrole-coated ceramic-polymeric membranes to model oily wastewater separation efficiency (SE) and permeate flux (PF) based on established experimental procedures. In this area, computational simulation still needs to be explored. The study developed predictive regression models, including robust linear regression (RLR), stepwise linear regression (SWR) and linear regression (LR) for the ceramic-polymeric porous membrane, aiming to interpret its complex performance across diverse conditions and, thus, develop its utility in oily wastewater treatment applications. Subsequently, a novel, simple average ensemble paradigm was explored to reduce errors and improve prediction skills. Prior to the development of the model, stability and reliability analysis of the data was conducted based on Philip Perron tests with the Bartlett kernel estimation method. The accuracy of the SE exhibited a high consistency, averaging 99.92% with minimal variability (standard deviation of 0.026%), potentially simplifying its prediction compared to PF. The modes were validated and evaluated using metrics like MAE, RMSE, Speed, and MSE, in addition to 2D graphical and cumulative distribution function graphs. The LR model emerged as the best with the lowest RMSE =0.21951, indicating superior prediction accuracy, followed closely by RLR with an RMSE = 0.22359. SWLR, while having the highest RMSE = 0.34573, marked its dominance in prediction speed with 110 observations per second. Notably, the RLR model justified a reduction in error by approximately 35.29% compared to SWLR. Moreover, the training efficiency of the LR model exceeded, demanding a mere 2.9252 s, marking a reduction of about 32.54% compared to SWLR. The improved simple ensemble learning proved merit over the three models regarding error accuracy. This study emphasizes the essential role of soft-computing learning in optimizing the design and performance of ceramic-polymeric membranes.
    Language English
    Publishing date 2024-04-15
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1171488-8
    ISSN 1873-3778 ; 0021-9673
    ISSN (online) 1873-3778
    ISSN 0021-9673
    DOI 10.1016/j.chroma.2024.464897
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top